These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 4633091)

  • 1. Evaluation of human cultured lymphoblasts as a source of antigen for production of immunosuppressive antilymphocyte serum.
    Sell K; Woody J; Smith J; Darrow C; Kayhoe D
    Transplant Proc; 1973 Mar; 5(1):541-7. PubMed ID: 4633091
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody titres of antilymphocytic sera and globulins determined by immunofluorescence and their correlation with immunosuppressive activity.
    Thomas D; Woodrooffe JG; Mosedale B; Ward PD; Zola H; Edwards DC; Balner H
    Clin Exp Immunol; 1972 Aug; 11(4):569-78. PubMed ID: 4628577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The production of immunosuppressive antisera.
    Barnes AD; Hawker RJ; Cowdall EI; Dickerson C; Dukes H; Griffin J; Crozier B; Fejfar J; Robinson BH; Blainey JD
    Proc Eur Dial Transplant Assoc; 1972; 9():364-70. PubMed ID: 4204156
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies in immuno-suppression. Methods to evaluate anti-human lymphocyte sera.
    Balner H; Dersjant H; van Bekkum DW
    Transplant Proc; 1969 Mar; 1(1):629-37. PubMed ID: 5002666
    [No Abstract]   [Full Text] [Related]  

  • 5. Properties of anti-dog lymphocytic globulin raised with two cell types and immunization schedules.
    Collste LG; Groth CG; Kashiwagi N; Schantz B; Svehag SE
    Acta Chir Scand; 1972; 138(8):775-80. PubMed ID: 4565722
    [No Abstract]   [Full Text] [Related]  

  • 6. Rosette formation by peripheral lymphocytes. II. Inhibition of the phenomenon.
    Brain P; Gordon J
    Clin Exp Immunol; 1971 Mar; 8(3):441-9. PubMed ID: 4995960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical use of antilymphocyte globulin.
    Najarian JS; Simmons RL
    N Engl J Med; 1971 Jul; 285(3):158-66. PubMed ID: 4103453
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antilymphocyte serum: choice of antigen for its preparation and immunosuppression tests].
    Traeger J; Fries D; Perrin J; Saubier E; Revillard JP; Brochier J; Dubernard JM; Carraz M; Plan M; Archimbaud JP
    J Urol Nephrol (Paris); 1969 Sep; 75(9):584-9. PubMed ID: 4997175
    [No Abstract]   [Full Text] [Related]  

  • 9. Production of antilymphocyte serum for use in dogs and test of its immunosuppressive potency.
    Rowiński W; Szmidt J; Brühl A; Dziedziul S; Tupalska B; Baraniewski H; Grupińska E; Opertowski A; Nielubowicz J
    Pol Med J; 1971; 10(2):425-30. PubMed ID: 4934232
    [No Abstract]   [Full Text] [Related]  

  • 10. Antilymphocyte serum (ALS) as an immunosuppressive agent in transplantation of the canine larynx. I. Preparation of antilymphocyte serum.
    Mogi G; Harvey JE; Ohyama M; Ueda N; Ogura JH
    Laryngoscope; 1972 Jan; 82(1):61-73. PubMed ID: 4109440
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of in vitro, immunosuppressive and clinical effects of goat and horse anti-human thymocyte globulin in Macaca monkeys.
    Kelly GE; Sheil AG; Mears DC
    Clin Exp Immunol; 1973 Apr; 13(4):585-94. PubMed ID: 4197827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cape Western baboon in organ allotransplantation.
    Murphy GP; Brede HD; Cohen E; Grace JT
    Transplant Proc; 1970 Dec; 2(4):546-9. PubMed ID: 5000235
    [No Abstract]   [Full Text] [Related]  

  • 13. Homograft survival and serum-blocking factors.
    Quadracci LJ; Pierce GE; Striker GE; Tremann JA; Marchioro TL
    Transplant Proc; 1973 Mar; 5(1):649-53. PubMed ID: 4572123
    [No Abstract]   [Full Text] [Related]  

  • 14. A standardized ALG for use in man.
    Thomas J; Hume DM
    Transplant Proc; 1972 Dec; 4(4):477-9. PubMed ID: 4118964
    [No Abstract]   [Full Text] [Related]  

  • 15. The production of antilymphocytic serum.
    Woiwod AJ
    Proc R Soc Med; 1970 Sep; 63(9):949-50. PubMed ID: 4991013
    [No Abstract]   [Full Text] [Related]  

  • 16. The reduction of antigenicity of heterologous antilymphocyte serum with acid Taka-protease.
    Amemiya H; Yokoyama T; Torisu M; Putnam CW; Anderson JT; Starzl TE
    Clin Exp Immunol; 1972 May; 11(1):67-81. PubMed ID: 4624986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabbit anti-human thymocyte globulin (RAHTG): in vitro and in vivo testing.
    Thomas J; Millington M; Volk M; Thomas F; Hume D
    Transplant Proc; 1974 Dec; 6(4):395-8. PubMed ID: 4140592
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental and clinical administration of cytotoxic antilymphocyte serum and antilymphocyte globulin in homologous skin transplantation].
    Spasokukots'kii IuO; Gorodets'ka SF; Timoshenko IuG
    Fiziol Zh; 1971; 17(3):341-5. PubMed ID: 4118041
    [No Abstract]   [Full Text] [Related]  

  • 19. Prediction of immunosuppressive potency of antilymphocyte serum by in vitro testing.
    Gill PG; Venables W; Ludbrook J
    J Immunol; 1971 Jul; 107(1):244-51. PubMed ID: 4933404
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro studies on the mechanism of action of human antithymocyte globulin.
    Thomas JM; Thomas F; Williams E; Scott J
    Proc Clin Dial Transplant Forum; 1977; 7():141-7. PubMed ID: 98764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.